| 1 |
Appiah MG, Park EJ, Akama Y, Nakamori Y, Kawamoto E, Gaowa A, Shimaoka M. Cellular and Exosomal Regulations of Sepsis-Induced Metabolic Alterations. Int J Mol Sci 2021;22:8295. [PMID: 34361061 DOI: 10.3390/ijms22158295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Feng J, Liu L, He Y, Wang M, Zhou D, Wang J. Novel insights into the pathogenesis of virus-induced ARDS: review on the central role of the epithelial-endothelial barrier. Expert Rev Clin Immunol 2021;:1-11. [PMID: 34224287 DOI: 10.1080/1744666X.2021.1951233] [Reference Citation Analysis]
|
| 3 |
Rong QX, Wang F, Guo ZX, Hu Y, An SN, Luo M, Zhang H, Wu SC, Huang HQ, Fu LW. GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer/T cell lymphoma. Mol Cancer 2021;20:80. [PMID: 34051805 DOI: 10.1186/s12943-021-01374-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 4 |
Lotfi N, Zhang GX, Esmaeil N, Rostami A. Evaluation of the effect of GM-CSF blocking on the phenotype and function of human monocytes. Sci Rep 2020;10:1567. [PMID: 32005854 DOI: 10.1038/s41598-020-58131-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 5 |
Lotfi N, Thome R, Rezaei N, Zhang GX, Rezaei A, Rostami A, Esmaeil N. Roles of GM-CSF in the Pathogenesis of Autoimmune Diseases: An Update. Front Immunol 2019;10:1265. [PMID: 31275302 DOI: 10.3389/fimmu.2019.01265] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 20.3] [Reference Citation Analysis]
|
| 6 |
He Y, Wen Q, Yao F, Xu D, Huang Y, Wang J. Gut-lung axis: The microbial contributions and clinical implications. Crit Rev Microbiol 2017;43:81-95. [PMID: 27781554 DOI: 10.1080/1040841X.2016.1176988] [Cited by in Crossref: 121] [Cited by in F6Publishing: 105] [Article Influence: 17.3] [Reference Citation Analysis]
|
| 7 |
Brown KA, Brown GA, Lewis SM, Beale R, Treacher DF. Targeting cytokines as a treatment for patients with sepsis: A lost cause or a strategy still worthy of pursuit? Int Immunopharmacol 2016;36:291-9. [PMID: 27208433 DOI: 10.1016/j.intimp.2016.04.041] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 8 |
Xu D, Huang Y, Wang J. Gut microbiota modulate the immune effect against hepatitis B virus infection.Eur J Clin Microbiol Infect Dis. 2015;34:2139-2147. [PMID: 26272175 DOI: 10.1007/s10096-015-2464-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
|
